260 related articles for article (PubMed ID: 19029192)
1. A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma.
Purdue MP; Lan Q; Wang SS; Kricker A; Menashe I; Zheng TZ; Hartge P; Grulich AE; Zhang Y; Morton LM; Vajdic CM; Holford TR; Severson RK; Leaderer BP; Cerhan JR; Yeager M; Cozen W; Jacobs K; Davis S; Rothman N; Chanock SJ; Chatterjee N; Armstrong BK
Carcinogenesis; 2009 Feb; 30(2):275-81. PubMed ID: 19029192
[TBL] [Abstract][Full Text] [Related]
2. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
[TBL] [Abstract][Full Text] [Related]
3. Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer.
Chen YC; Giovannucci E; Kraft P; Lazarus R; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1982-9. PubMed ID: 17932345
[TBL] [Abstract][Full Text] [Related]
4. Full-exon resequencing reveals toll-like receptor variants contribute to human susceptibility to tuberculosis disease.
Ma X; Liu Y; Gowen BB; Graviss EA; Clark AG; Musser JM
PLoS One; 2007 Dec; 2(12):e1318. PubMed ID: 18091991
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in the toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk.
Stevens VL; Hsing AW; Talbot JT; Zheng SL; Sun J; Chen J; Thun MJ; Xu J; Calle EE; Rodriguez C
Int J Cancer; 2008 Dec; 123(11):2644-50. PubMed ID: 18752252
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in DNA repair genes, hair dye use, and the risk of non-Hodgkin lymphoma.
Guo H; Bassig BA; Lan Q; Zhu Y; Zhang Y; Holford TR; Leaderer B; Boyle P; Qin Q; Zhu C; Li N; Rothman N; Zheng T
Cancer Causes Control; 2014 Oct; 25(10):1261-70. PubMed ID: 25178586
[TBL] [Abstract][Full Text] [Related]
7. Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk.
Wang SS; Purdue MP; Cerhan JR; Zheng T; Menashe I; Armstrong BK; Lan Q; Hartge P; Kricker A; Zhang Y; Morton LM; Vajdic CM; Holford TR; Severson RK; Grulich A; Leaderer BP; Davis S; Cozen W; Yeager M; Chanock SJ; Chatterjee N; Rothman N
PLoS One; 2009; 4(4):e5360. PubMed ID: 19390683
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in complement system genes and risk of non-Hodgkin lymphoma.
Bassig BA; Zheng T; Zhang Y; Berndt SI; Holford TR; Hosgood HD; Hu W; Leaderer B; Yeager M; Menashe I; Boyle P; Xu J; Zou K; Zhu Y; Chanock S; Rothman N; Lan Q
Environ Mol Mutagen; 2012 Mar; 53(2):145-51. PubMed ID: 22170086
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in TLR1, TLR6 and TLR10 genes and the risk of Graves' disease.
Xiao W; Liu Z; Lin J; Li J; Wu K; Ma Y; Gong Y; Liu Z
Autoimmunity; 2015 Feb; 48(1):13-8. PubMed ID: 25028161
[TBL] [Abstract][Full Text] [Related]
10. A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region.
Cerhan JR; Fredericksen ZS; Novak AJ; Ansell SM; Kay NE; Liebow M; Dogan A; Cunningham JM; Wang AH; Witzig TE; Habermann TM; Asmann YW; Slager SL
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1799-806. PubMed ID: 22911334
[TBL] [Abstract][Full Text] [Related]
11. Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk.
Sun J; Wiklund F; Hsu FC; Bälter K; Zheng SL; Johansson JE; Chang B; Liu W; Li T; Turner AR; Li L; Li G; Adami HO; Isaacs WB; Xu J; Grönberg H
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):480-5. PubMed ID: 16537705
[TBL] [Abstract][Full Text] [Related]
12. C-X-C chemokine receptor type 5 gene polymorphisms are associated with non-Hodgkin lymphoma.
Song H; Tong D; Cha Z; Bai J
Mol Biol Rep; 2012 Sep; 39(9):8629-35. PubMed ID: 22707196
[TBL] [Abstract][Full Text] [Related]
13. C677T and A1298C polymorphisms of methylene tetrahydrofolate reductase in non-Hodgkin lymphoma: southeast Iran.
Mashhadi MA; Miri-Moghaddam E; Arbabi N; Bazi A; Heidari Z; Sepehri Z; Karimkoshte A; Rezvan A; Hashemi SM
Tumori; 2018 Aug; 104(4):280-284. PubMed ID: 28430351
[TBL] [Abstract][Full Text] [Related]
14. Single Nucleotide Polymorphisms in
Ortega E; Hernández-Bazán S; Sánchez-Hernández B; Licona-Limón I; Fuentes-Dominguez J
J Immunol Res; 2020; 2020():2965697. PubMed ID: 32411792
[TBL] [Abstract][Full Text] [Related]
15. Lack of association of three common polymorphisms in toll-like receptors (TLRs), TLR2+597T>C, +1350C>T and Arg753Gln with cancer risk: a meta-analysis.
Yang X; Wang XX; Qiu MT; Hu JW; Yin R; Xu L; Zhang Q
Asian Pac J Cancer Prev; 2013; 14(10):5871-6. PubMed ID: 24289592
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in ghrelin and neuropeptide Y genes are associated with non-Hodgkin lymphoma.
Skibola DR; Smith MT; Bracci PM; Hubbard AE; Agana L; Chi S; Holly EA
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1251-6. PubMed ID: 15894681
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms in TLR1, TLR2, TLR4, and TLR10 of Helicobacter pylori-associated gastritis: a prospective cross-sectional study in Thailand.
Tongtawee T; Bartpho T; Kaewpitoon S; Kaewpitoon N; Dechsukhum C; Leeanansaksiri W; Loyd RA; Talabnin K; Matrakool L; Panpimanmas S
Eur J Cancer Prev; 2018 Mar; 27(2):118-123. PubMed ID: 28368946
[TBL] [Abstract][Full Text] [Related]
18. Genetic variation in H2AFX contributes to risk of non-Hodgkin lymphoma.
Novik KL; Spinelli JJ; Macarthur AC; Shumansky K; Sipahimalani P; Leach S; Lai A; Connors JM; Gascoyne RD; Gallagher RP; Brooks-Wilson AR
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1098-106. PubMed ID: 17548670
[TBL] [Abstract][Full Text] [Related]
19. Sequence variants in the TLR4 and TLR6-1-10 genes and prostate cancer risk. Results based on pooled analysis from three independent studies.
Lindström S; Hunter DJ; Grönberg H; Stattin P; Wiklund F; Xu J; Chanock SJ; Hayes R; Kraft P
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):873-6. PubMed ID: 20200442
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases.
Pierik M; Joossens S; Van Steen K; Van Schuerbeek N; Vlietinck R; Rutgeerts P; Vermeire S
Inflamm Bowel Dis; 2006 Jan; 12(1):1-8. PubMed ID: 16374251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
